English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Hybrid Compound Design to Overcome the Gatekeeper T338M Mutation in cSrc

MPS-Authors

Getlik,  Matthäus
Max Planck Institute of Molecular Physiology, Max Planck Society;

Grütter,  Christian
Max Planck Institute of Molecular Physiology, Max Planck Society;

Simard,  Jeffrey R.
Max Planck Institute of Molecular Physiology, Max Planck Society;

Klüter,  Sabine
Max Planck Institute of Molecular Physiology, Max Planck Society;

Rabiller,  Matthias
Max Planck Institute of Molecular Physiology, Max Planck Society;

Rode,  Haridas B.
Max Planck Institute of Molecular Physiology, Max Planck Society;

Robubi,  Armin
Max Planck Institute of Molecular Physiology, Max Planck Society;

/persons/resource/persons98721

Rauh,  Daniel
Chemical Genomics Center of the MPS, Max Planck Institute of Molecular Physiology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Getlik, M., Grütter, C., Simard, J. R., Klüter, S., Rabiller, M., Rode, H. B., et al. (2009). Hybrid Compound Design to Overcome the Gatekeeper T338M Mutation in cSrc. Journal of Medicinal Chemistry, 52(13): 1, pp. 3915-3926. Retrieved from http://dx.doi.org/10.1021/jm9002928.


Cite as: https://hdl.handle.net/11858/00-001M-0000-0014-037D-C
Abstract
There is no abstract available